Kairo Health Labs, Inc. — SEC Form D Filing
Kairo Health Labs, Inc. filed an SEC Form D on August 10, 2026, reporting $200K raised in Healthcare Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 10, 2026
- Amount reported
- $200K
- Round stage
- Seed
- Industry
- Healthcare Technology
- Website
- https://kairohealth.ai/
What the company does
Revenue: No Revenues. Incorporated: DELAWARE
Problem
Healthcare AI models often lack a robust safety evaluation layer, leading to potential failures such as hallucinated dosages, missed contraindications, and biased outputs, which could harm patients.
Solution
Kairo Health Labs provides an AI safety infrastructure that simulates clinical environments to stress-test healthcare AI models against edge cases and validate their safety, generating an auditable record before deployment.
Why now
The rapid advancement and increasing adoption of AI and large language models in healthcare necessitate robust safety and evaluation protocols to prevent patient harm and build trust in these technologies. Regulatory bodies and medical boards are increasingly focused on the responsible deployment of AI in clinical settings.
Verdict
Investors backed this because the market was beginning to grapple with AI safety implications, not because Kairo Health Labs had a proven technical moat. They were implicitly betting on early regulatory pressures creating a top-down mandate for specialized validation tools in healthcare AI. The upside was limited by the nascent and undefined nature of clinical AI safety standards, risking Kairo Health Labs becoming a feature rather than a standalone platform if the market converged on simpler, integrated solutions.
Source: SEC EDGAR Form D filing